Diagnosis and Management of Kawasaki Disease
Authors:
- 1 March 2019
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 173 (3) , 278-279
Abstract
This Clinical Guidelines Synopsis describes the updates and recommendations of the American Heart Association Scientific Statement: Diagnosis, Treatment, and LoKeywords
This publication has 8 references indexed in Scilit:
- Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart AssociationCirculation, 2017
- Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysisHeart, 2012
- Evaluation of Kawasaki Disease Risk-Scoring Systems for Intravenous Immunoglobulin ResistanceThe Journal of Pediatrics, 2011
- Performance of 2004 American Heart Association Recommendations for Treatment of Kawasaki DiseasePediatrics, 2010
- Increased Detection Rate of Kawasaki Disease Using New Diagnostic Algorithm, Including Early Use of EchocardiographyThe Journal of Pediatrics, 2009
- Diagnosis, Treatment, and Long-Term Management of Kawasaki DiseaseCirculation, 2004
- American College of Cardiology/American Heart Association Clinical Practice Guidelines: Part ICirculation, 2003
- Kawasaki Syndrome, Reye Syndrome, and AspirinPediatrics, 1986